ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 112  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      N27050 yx19e05.r1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:262208 5' similar to gb:X57138_rna1 HISTONE H2B.2 (HUMAN), mRNA sequence. 327 mRNA Homo sapiens
      MD273183 JP 2020517247-A/27050: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof. 20 DNA synthetic construct
      HW862274 JP 2015051004-A/27002: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      MB765741 JP 2018535655-A/29638: ASGR INHIBITORS. 107 PRT synthetic construct
      LX124666 JP 2017506877-A/27048: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes. 16 DNA synthetic construct
      OG756569 JP 2021120380-A/27050: CANCER NEOEPITOPES. 9 PRT Homo sapiens
      LF686271 JP 2016521556-A/27050: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION. 15 DNA Homo sapiens
      FU801531 JP 2009528046-A/27048: Method for identifying useful proteins of brewery yeast. 25 DNA Saccharomyces pastorianus
      DL908794 JP 2014205669-A/27050: Method of constructing and screening libraries of peptide structures. 24 PRT synthetic construct
      DJ156430 JP 2007228956-A/27048: Method for identification of useful proteins derived from brewery yeast. 25 DNA Saccharomyces pastorianus
      MD759292 JP 2019507579-A/27050: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY. 20 DNA synthetic construct
      DL617652 JP 2011092200-A/27050: NEISSERIAL ANTIGENIC PEPTIDES. 7 PRT Neisseria
      DL036064 JP 2005512499-A/27050: Diagnosis of existing illnesses or that praedisposition for determined illnesses. 588 DNA synthetic construct
      HW192078 JP 2013102767-A/27002: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      MC910788 JP 2018536623-A/27050: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF. 37 PRT synthetic construct
      PD714964 JP 2021530475-A/27046: De novo Design of Protein Switches. 55 PRT synthetic construct
      PD733286 JP 2022502046-A/37102: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY. 7 PRT synthetic construct
      DJ530850 JP 2010517930-A/27050: Method of constructing and screening libraries of peptide structures. 24 PRT synthetic construct
      HV883591 JP 2010507387-A/27002: Novel siRNAs and Methods of Use Thereof. 21 RNA synthetic construct
      MC168894 JP 2019500349-A/27050: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. 18 RNA synthetic construct
      DM763744 JP 2014079248-A/27050: NEISSERIAL ANTIGENIC PEPTIDES. 7 PRT Neisseria
      MC555549 JP 2019525738-A/27049: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES. 107 PRT synthetic construct
      MC779160 JP 2018525446-A/27050: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 29 PRT synthetic construct
      OG663436 JP 2021500321-A/27050: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES. 189 PRT synthetic construct
      PA397773 JP 2021533803-A/26856: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE. 26 DNA Homo sapiens
      DM801508 JP 2014068652-A/27050: NEISSERIAL ANTIGENIC PEPTIDES. 7 PRT Neisseria
      OG511236 JP 2018534252-A/27050: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF. 38 PRT synthetic construct
      DD553653 JP 2004508801-A/27050: NEISSERIAL ANTIGENIC PEPTIDES. 7 PRT Neisseria
      DM412236 JP 2009524404-A/26222: GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION, METHODS OF DETECTION AND USES THEREOF. 201 DNA Homo sapiens
      MA194978 JP 2017060532-A/26222: GENETIC POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL INFARCTION, METHODS OF DETECTION AND USES THEREOF. 201 DNA Homo sapiens
      Now loading
      PAGE TOP